( September 25, 2025, 1:33 PM EDT) -- SAN DIEGO — A federal judge in California dismissed a pension fund’s class action complaint against a biopharmaceutical company and certain of its executives after the company’s stock price dropped when a collaborating company ended their collaboration agreement, finding that while it alleged sufficient facts to satisfy falsity and scienter requirements under Section 10(b) of the Securities Exchange Act of 1934, the pension fund did not sufficiently allege that its losses were caused by the company’s alleged misstatements....